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Abstract To identify association of IL18-607 C/A and -137
G/C polymorphism with susceptibility to gout in Chinese
Han male population, We evaluate the genetic contribution
of the IL18-607 C/A and -137 G/C polymorphism in 202
gout male patients and 493 gout-free control of Chinese
Han population by allele-speciWc polymerase chain reaction
assay. Our results reveal no signiWcant association between
the polymorphisms -607C/A and -137G/C in IL18 with
gout. Our study might suggest that -607 C/A and -137 G/C
polymorphisms in the promoter of IL18 are not associated
with susceptibility to gout and thus do not play a major role in
the development of gout in the Chinese Han male population.
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Introduction
Gout is often caused by deposition of monosodium urate
crystals in the joint to induce acute attacks of arthritis
inXammation, which develops into involvement of the joint
deformity and dysfunction. Recently, with the improve-
ment of social prosperity and the variation of diet structure,
the prevalence and epidemiology of this disorder are more
complex than was once thought, and have become the com-
mon inXammatory joint illness in men above 40 years of
age especially in Chinese coast region. The epidemiological
investigation of more than 5,000 residents from coast of
Shandong province in 2004 indicated that the prevalence of
gout was about 0.84%, in men 1.94% and women 0.42% [1].
Previous research suggested that gout is in association
with some of process such as activation of nuclear factor
(NF)-kB and transcription production and secretion of
IL1beta and activation of the inXammasome [2]. As a mem-
ber of the IL1 superfamily, IL18, generated by activated
mononuclear macrophage, is one of the widely distributed
proinXammatory cytokines [3] and plays an important role in
regulating the innate and adaptive immune systems [4]. Its
two functional variants at positions -607 C/A (rs1946518)
and -137 G/C (rs187238) in the promoter region of the IL18
gene have important eVect on its transcription activity [5].
To test the hypothesis that -607 C/A and -137 G/C poly-
morphisms in IL18 may inXuence disposition to gout devel-
opment, the present study was conducted on the possible
genetic association between this polymorphism and gout in
a Chinese Han male population.
Materials and methods
Study population
A total of 202 gout male patients and 493 gout-free male
controls were recruited in this study from Medical School
Hospital of Qingdao University. The diagnosis of gout was
based on the preliminary criteria, which were published by
the American College of Rheumatology in 1997 for the
classiWcation of gout for use in either clinical settings or
population-based epidemiologic studies. All subjects were
provided written informed consent, and study protocol was
approved by the Ethics Committee of Medical School
Hospital of Qingdao University.
C. Li and Y. Yuan have contributed equally to the work.
C. Li · Y. Yuan · X. Wang · L. Han · N. Chu · H. Wang · S. Liu (&)
Gout Laboratory, Medical School Hospital of Qingdao University, 
16 Jiangsu Road, Qingdao 266003, China
e-mail: qdmc_genetics@163.com123
1806 Rheumatol Int (2012) 32:1805–1807DNA analysis and statistical analysis
Genomic DNA was extracted from whole blood samples
using standard methods. Genotyping of each subject for the
presence of -607 C/A and -137 G/C SNPs in the promoter
of IL18 was performed using a previously described allele-
speciWc polymerase chain reaction assay [6]. In addition,
several subjects were selected to conWrm genotype by DNA
sequencing techniques. For all data of patients and controls,
the Hardy–Weinberg equilibrium of the genotype distribu-
tion was tested using the homogeneity  square test. A
case–control study was performed using the homogeneity 
square test.
Results
A total of 202 gout patients and 493 gout-free controls
participated in this study. The genotypic distribution was
not signiWcantly diVerent from the distribution expected
according to Hardy–Weinberg equilibrium in gout patients
(for -607 C/A, 2 = 2.52 with 1 df and P = 0.112; for -137G/
C, 2 = 2.306 with 1 df and P = 0.115) and control group (for
-607 C/A, 2 = 2.478 with 1 df and P = 0.115; for -137G/C,
2 = 0.418 with 1 df and P = 0.517). No signiWcant diVer-
ences were found in -607C/A and -137G/C genotypic and
allelic frequencies between gout cases and controls (for -607
C>A, 2 = 0.320, df = 1, P = 0.851 by genotype; 2 = 0.071,
df = 1, P = 0.788 by allele; for -137G/C, 2 = 1.796, df = 1,
P = 0.407 by genotype; 2 = 1.193, df = 1, P = 0.274 by
allele).
Discussion
The previous studies indicated that IL18 plays an important
role in the immune regulation, anti-infection, and the patho-
genic process of chronic inXammatory diseases, and IL18
polymorphism in the promoter region has been noted asso-
ciated with many kinds of diseases, such as type 1 diabetes
[6], asthma [7], virus infective disease [8], rheumatoid
arthritis [9] and so on. As two functional polymorphism
position (-607 C/A and -137G/C) in the promoter of IL18,
Low promoter activity was observed for the A and C alleles
at positions -607 and -137, respectively. In contrast, higher
promoter activity was observed for the C and G alleles in
these positions [5].
In the present study, we evaluate the genetic contribution
of the IL18 -607 C/A and -137 G/C polymorphism in gout
patients and 493 gout-free controls of Chinese Han popula-
tion. Our results reveal no signiWcant association between
the polymorphisms -607C/A and -137G/C in IL18 with
gout. Although Inokuchi et.al detected the levels of IL18 in
the plasma of 31 male patients with gouty arthritis and
suggested that increased plasma levels of IL-18 reXect local
inXammation associated with gouty arthritis [10], our result
might suggest that IL18 promoter polymorphism is not
associated with susceptibility to gout and thus does not play
a major role in the development of gout in the Chinese Han
male population. To our knowledge, this is the Wrst report
on investigating SNPs in IL18 in relation to gout.
However, the present study has several limitations. First,
we chose only 2 SNP locus and did not include enough
polymorphic markers to cover the whole sequence of IL18.
So, the results of the present study should be interpreted
with caution. Second, the power of the present study was
limited by sample size. Last but not least, the lack of sig-
niWcance for IL18 polymorphisms in conferring liability to
gout disease does not exclude a role of diVerent functional
polymorphisms in genes coding for cytokine structures in
the etiology of gout. Thus, further investigations with more
polymorphic markers should be performed in a larger
sample of Chinese Han male population and diVerent popu-
lation to validate our Wndings.
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